P46362 2nd Annual Pharma Market Access and Pricing Summit Asia 2018
Download Brochure Request

Register your interest

Comments

Register your interest

Comments

2nd Annual Pharma Market Access and Pricing Summit Asia 2018

19 – 20 Sep 2018, One Farrer Hotel & Spa, Singapore

Register Your Interest Download Brochure

SPECIAL 1-FOR-1 OFFER ON NORMAL RATES FOR PHARMACEUTICAL COMPANIES*
LIMITED SEATS, APPLICABLE ONLY TO 2-DAY MAIN CONFERENCE DAYS.
SEE PRICING BELOW FOR MORE INFORMATION.

overview

Asia’s pharma markets are extremely complex with each country governed by very different healthcare policies, reimbursement schemes, unique pricing, with large risks involved in entering the market, particularly with high priced, specialty drugs/therapeutics. Once way is to overcome this is to out-license, which cuts risks but can also decrease profits. There is also no guarantee that this will lead to success.

2nd Annual Pharma Market Access Asia 2018 brings pharma and industry together to navigate the complex environments and lessons learnt from successfully and profitable market entries for orphan drugs, high priced therapeutics, generics, biosimilars and more.

“Excellent event! Looking at multiple perspective from patients, policy maker, prescriber, provider, and payers. Well done to the producer and organizing team!”
Sebastien Boisseau, Market Access Director, Mundipharma

Snapshot of 2018 Attendee List:

View »

Conference Highlights

  • Country Case Studies – On market access by Pharma companies
  • Growth Markets and Strategy Spotlight for Biosimilars, Generics, Orphan drugs, etc
  • Pricing and Reimbursement – Strategies for improving market access
  • Leveraging HEOR and RWE – In support of Market Access
  • Out Licensing and Partnerships – For successful collaboration models

Choose your language

Part of

Pharmacon Asia >>

Co-Located Events

Accelerating Clinical Trials in Asia >>
Pharma Regulatory Affairs Asia >>
Pharma Market Access and Pricing Summit Asia >>
Digital Pharma Summit >>

Sponsorship

Partnership and Profile Building Opportunities are Now Available!
Contact us today to find out how you can position your company as a market leader at this event, and to explore the range of branding and marketing opportunities available.

View Sponsors and Exhibitors profile >>

speakers

Danny Soon

Senior Director, Health and Biomedical Cluster, Biomedical Research Council (BMRC) A*STAR

Ho Weng Si

Director, Biomedical Sciences Group, Economic Development Board, Singapore

Kurt Scheinpflug

Senior Director of Digital Medicines Engineering, Proteus Digital Health, USA

Enver Erkan

Country Manager, Pfizer Singapore

Alexis Serlin

Asia Cluster Head, Novartis

Miguel Rivera

Global Digital Innovation Lead, Ferring Pharmaceuticals, Switzerland

How Ti-Hwei

Country President, AstraZeneca, Singapore

Jie Shen

Corporate Global Head of Pricing and Value Policy, Novartis, Switzerland

Jeff Weisel

Director, Life Sciences & Healthcare, Transaction Advisory Services, EY, Singapore

Gregory O’Toole

Reimbursement Strategy Specialist, AstraZeneca, Australia

Kathleen Yeoh

Director, Corporate Affairs and Market Access, ASEAN, Eli Lilly & Company, Malaysia

Cameron Milliner

Head of Public Affairs and Patient Advocacy - APAC, Shire, Singapore

Evelyn Pang

Head of Operations, Sanofi, Singapore

Sirinthip Petcharapiruch

Head of HEOR, Real-World Insights, IQVIA Asia Pacific

Yuki Sato

Representative Director, Deallus Consulting, Japan

Bruce Crawford

Vice President, Real-World & Late Phase, Syneos Health

Xingzhi Wang

Oncology HEOR Lead (Asia & Oceania), Astellas Pharma, Singapore

Min Su

Head of Health and Wellness Strategy Management, AIA International Limited, Hong Kong

Chan Wing Sze Cherry

Group Medical Advisor, AIA, Hong Kong

Yoshihiro Suwa

Partner, Head of Healthcare Southeast Asia, PT Roland Berger, Indonesia

Nathan Kothandaraman

Market Access & Government Affairs, Johnson & Johnson, Malaysia

Teck Jack Tan

Medical Director, Northeast Medical Group, Singapore

Timothy Low

Board of Director, Farrer Park Hospital l APAC Medical Head, Shire l Board of Director, PACRA, Singapore

Yu-Wen Huang

Senior Executive Officer, Medical Review and Pharmaceutical Benefits Division, National Health Insurance Administration, Ministry of Health and Welfare, Taiwan

Waranya Rattanavipapong

Head of International Unit, Health Intervention and Technology Assessment Program (HITAP), Ministry of Public Health, Thailand

Neal Somchand

Principal, Deallus Consulting, Japan

Hang Le

APAC Regional Market Access Lead, Roche, Singapore

Manoj Saxena

Director Regional Market Access, Asia-Pacific, Bayer, Singapore

Mathew Thomas

Head, Public Affairs, Value Demonstration and Access - SEA, Shire, Singapore

Hazel Dy Tioco

Asia Pacific Regional Director, Study Management and Logistics, Sanofi, Philippines

Yaron Turpaz

Chief Data & Technology Officer, Managing Director, Global Gene Corp, Singapore

Harish Dave

Co-Founder and Chief Medical Officer, Aum Biosciences, Singapore

when & where

19 - 20 Sep 2018

One Farrer Hotel & Spa
1 Farrer Park Station Road
Singapore 217562

Contact Person: Daniel Koh
DDI: (+65) 6705 7884
Fax: (+65) 6834 7892
Cell: (+65) 86870123
Email: danielkoh@onefarrer.com

contact

Still have a question?

Speaking Opportunities
Siang Yee Yeo
+65-6508 2446
SiangYee.Yeo@ibcasia.com.sg

Sponsorship Opportunities
Yvonne Leong
+65 6508 2489

Yvonne.Leong@ibcasia.com.sg

Media & Association Partnership Opportunities
June Tan
+65 6508 2465
June.Tan@ibcasia.com.sg

STAY UPDATED ON OUR NEWS & EVENTS

IBC Asia is Singapore's leading event organiser. We conceive, develop and promote our own B2B industry conferences and corporate training courses, and offer tailored managed event solutions.

Find out more